Related Experiment Video

Updated: Aug 18, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and malignant thyroid tumors

L A T Arnaldi1, R C Borra, R M B Maciel

  • 1Laboratory of Molecular Endocrinology, Division of Endocrinology, Department of Medicine, Federal University of São Paulo, Rua Pedro de Toledo 781-12 andar 04039-032, São Paulo, Brazil.

Thyroid : Official Journal of the American Thyroid Association
|March 24, 2005
PubMed

Insights

Researchers identified key gene expression changes in thyroid tumors. Specific genes like DCN, DIO1, and DIO2 were underexpressed, offering potential diagnostic markers and therapeutic targets for thyroid cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Thyroid tumors exhibit complex molecular alterations.
  • Understanding gene expression profiles is crucial for pathogenesis and progression insights.

Purpose of the Study:

  • To identify differentially expressed genes in thyroid carcinoma cell lines compared to normal thyroid tissue.
  • To validate candidate genes as potential biomarkers and therapeutic targets for thyroid tumors.

Main Methods:

  • Utilized cDNA array methodology to analyze 1807 expressed sequence tags (ESTs).
  • Applied stringent criteria to identify significantly underexpressed or overexpressed transcripts.
  • Validated candidate genes using quantitative polymerase chain reaction (qPCR) on independent thyroid tumor and normal tissue samples.

Main Results:

  • Identified 505 differentially expressed transcripts in thyroid carcinoma cell lines.
  • Detected 55 ESTs with significant ( >5-fold) differential expression.
  • Found DCN underexpression in follicular adenomas and carcinomas, and DIO1/DIO2 underexpression in papillary thyroid carcinomas.

Conclusions:

  • Specific gene expression patterns, including DCN, DIO1, and DIO2 underexpression, characterize thyroid tumors.
  • These genes may serve as diagnostic signatures for thyroid tumors.
  • Identified genes represent potential therapeutic targets for thyroid tumor treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...